ozenoxacin cream impetigo
Selected indexed studies
- Topical Ozenoxacin Cream 1% for Impetigo: A Review. (J Drugs Dermatol, 2019) [PMID:31334625]
- Ozenoxacin 1% cream (Xepi) for impetigo. (Med Lett Drugs Ther, 2019) [PMID:31169810]
- ** (, 2018) [PMID:30942989]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Topical Ozenoxacin Cream 1% for Impetigo: A Review. (2019) pubmed
- Ozenoxacin 1% cream (Xepi) for impetigo. (2019) pubmed
- PMID:30942989 (2018) pubmed
- PMID:30942991 (2018) pubmed
- Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo. (2020) pubmed
- Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial. (2014) pubmed
- Ozenoxacin Cream, 1% - Topical Treatment of Impetigo. (2017) pubmed
- Retrospective Analysis of the Real-World Use of Topical Antimicrobials in the Paediatric Population with Impetigo in Italy: Focus on the Role of Ozenoxacin 1% Cream. (2023) pubmed
- PMID:30933450 (2018) pubmed
- Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial. (2018) pubmed